Press Releases
Search
-
26 Jun 2019
bioMérieux et l’État de Côte d’Ivoire inaugurent le Centre de formation bioMérieux et signent un accord de collaboration
L’État de Côte d’Ivoire et bioMérieux, acteur mondial du diagnostic in vitro, annoncent la signature d’un mémorandum d’accord de collaboration à l’occasion de l’inauguration du Centre de formation de ...
-
06 Jun 2019
bioMérieux increases its holding in Hybiome from 54% to 67%
bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier...
-
13 May 2019
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS “Guidelines for Perioperative Care in Cardiac Surgery”
The NEPHROCHECK® Test biomarkers (TIMP-2 and IGFBP7) that indicate kidney stress in advance of acute kidney injury (AKI) have been included in the “Guidelines for Perioperative Care in Cardiac Surgery...
-
24 Apr 2019
bioMérieux – First-Quarter 2019 Business Review
Organic growth of 3.8% (at constant exchange rates and scope of consolidation) €632 million in sales Up 7.7% as reported Growth led by the performance in molecular biology, during a first quarter shap...
-
15 Apr 2019
“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients
bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp announced at ECCMID (European Congress of Clinical Microbiology...
-
02 Apr 2019
University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 - The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicine...